25 years of HIV research! ... and what about a vaccine?

被引：6

作者：

Appay, Victor ^{[1
]}

机构：

[1] Univ Paris 06, INSERM, Hop La Pitie Salpetriere, Avenir Grp,UMR S 945, F-75013 Paris, France

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2009年 / 39卷 / 08期

关键词：

AIDS; Diversity; T-cells; Vaccine; CD8(+) T-CELLS; IMMUNODEFICIENCY VIRUS-INFECTION; IMMUNE CONTROL; NEUTRALIZING ANTIBODIES; ANTIRETROVIRAL THERAPY; DENDRITIC CELLS; RHESUS-MONKEYS; IN-VIVO; RESPONSES; ANTIGEN;

D O I：

10.1002/eji.200939551

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Over the past quarter century, colossal progress in our understanding of HIV pathogenesis has been achieved. Yet, we have no solution to the pandemic; the search for an HIV vaccine remains among the highest public health priorities. Identifying correlates of immune protection in humans, inducing effective immunity through immunization, and overcoming virus and host diversity represent the major obstacles in vaccine development. HIV vaccine research discovery may only be at its dawn.

引用

页码：1999 / 2003

页数：5

共 50 条

[41] Development of a novel AIDS vaccine: the HIV-1 transactivator of transcription protein vaccine
Cafaro, Aurelio
Tripiciano, Antonella
Sgadari, Cecilia
Bellino, Stefania
Picconi, Orietta
Longo, Olimpia
Francavilla, Vittorio
Butto, Stefano
Titti, Fausto
Monini, Paolo
Ensoli, Fabrizio
Ensoli, Barbara
EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 : S13 - S29
[42] Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials
Fischinger, Stephanie
Cizmeci, Deniz
Deng, Davy
Grant, Shannon P.
Frahm, Nicole
McElrath, Julie
Fuchs, Jonathan
Bart, Pierre-Alexandre
Pantaleo, Giuseppe
Keefer, Michael
Hahn, William O.
Rouphael, Nadine
Churchyard, Gavin
Moodie, Zoe
Donastorg, Yeycy
Streeck, Hendrik
Alter, Galit
PLOS PATHOGENS, 2021, 17 (11)
[43] HIV/AIDS Vaccine
Choi, Jun Yong
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2007, 50 (04): : 337 - 342
[44] WHAT DO CZECH ADOLESCENTS KNOW ABOUT HIV?
Miculkova, Veronika
Fialova, Alena
Kovacic, Tanja
Hamplova, Lidmila
Vesely, Dan
Hulinsky, Petr
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 26 (02) : 149 - 153
[45] Prospects for a vaccine to prevent HIV-related tuberculosis
Nemes, Elisa
Scriba, Thomas J.
Hatherill, Mark
CURRENT OPINION IN HIV AND AIDS, 2018, 13 (06) : 522 - 527
[46] Phase III HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV
Vaccari, Monica
Poonam, Poonam
Franchini, Genoveffa
EXPERT REVIEW OF VACCINES, 2010, 9 (09) : 997 - 1005
[47] Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: What are the "cGMP"?
Sheets, Rebecca L.
Rangavajhula, Vijaya
Pullen, Jeffrey K.
Butler, Chris
Mehra, Vijay
Shapiro, Stuart
Pensiero, Michael
VACCINE, 2015, 33 (15) : 1757 - 1766
[48] Vaccine adjuvants: A priority for vaccine research
Harandi, Ali M.
Medaglini, Donata
Shattock, Robin J.
VACCINE, 2010, 28 (12) : 2363 - 2366
[49] A Zigzag but Upward Way to Develop an HIV-1 Vaccine
Wen, Ziyu
Sun, Caijun
VACCINES, 2020, 8 (03) : 1 - 17
[50] HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine
Graziani, Gina M.
Angel, Jonathan B.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (07) : 953 - 966

← 1 2 3 4 5 →